Clinical Trial Update: A Study of XS-04 in Patients with Relapsed or Refractory Hematologic Malignancies [Phase 1]

View source ↗

Summary

Phase 1 study of XS-04 in relapsed or refractory hematologic malignancies, including B-cell lymphoma, acute myeloid leukemia, and myelodysplastic syndrome, curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• B-cell Lymphoma
• Myelodysplastic Syndrome

Drugs mentioned

• XS-04

Snippet

Sponsor: NovaOnco Therapeutics Co., Ltd. | Conditions: B-cell Lymphoma, Acute Myeloid Leukemia | Phase 1 | Status: RECRUITING